Correlation Between Travere Therapeutics and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Travere Therapeutics and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Hepion Pharmaceuticals.
Diversification Opportunities for Travere Therapeutics and Hepion Pharmaceuticals
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Travere and Hepion is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Travere Therapeutics and Hepion Pharmaceuticals
Given the investment horizon of 90 days Travere Therapeutics is expected to generate 0.53 times more return on investment than Hepion Pharmaceuticals. However, Travere Therapeutics is 1.89 times less risky than Hepion Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 1,890 in Travere Therapeutics on September 2, 2024 and sell it today you would lose (9.00) from holding Travere Therapeutics or give up 0.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Travere Therapeutics vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Travere Therapeutics |
| Hepion Pharmaceuticals |
Travere Therapeutics and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Travere Therapeutics and Hepion Pharmaceuticals
The main advantage of trading using opposite Travere Therapeutics and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Travere Therapeutics vs. Tff Pharmaceuticals | Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. Inhibrx | Travere Therapeutics vs. Enliven Therapeutics |
| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |